HuM&C Sees Strong Performance Growth with Vibrant Operation of Vietnam Plant

HuM&C, a healthcare packaging materials specialist under Huons Group, is achieving improved performance and profitability, driven by the full-scale operation of its medical container plant in Vietnam.

A view of HuM&C Vina, the HuM&C production factory in Vietnam. Photo by HuM&C

According to the industry on July 8, HuM&C was established in 2002 and manufactures healthcare packaging materials such as medical and cosmetic glass containers, including ampoules, as well as cosmetic accessories. Building on the launch of its Vietnam production plant, 'HuM&C Vina,' the company has expanded its business domains and increased production capacity while continuously investing in research and development (R&D) for future growth, laying the foundation for further progress.

'HuM&C Vina' is Huons Group’s first overseas production base and serves as HuM&C’s Vietnam subsidiary. Located in Hung Yen Province, Vietnam, the plant spans approximately 14,876 square meters (about 4,500 pyeong) and is equipped with an annual production capacity of around 60 million vials and 90 million cartridges.

The Vietnam plant began full-scale operation of its production lines in the second quarter of last year, officially taking on the role of an overseas manufacturing hub. To ensure stable operations, HuM&C made multifaceted efforts, including active local recruitment and workforce training. The company is also striving to identify new clients to boost sales by fully utilizing the increased production capacity enabled by the new facility.

In the first quarter of this year, HuM&C posted record-high quarterly results. Based on the consolidated financial statements for the first quarter, sales reached 14.5 billion won and operating profit was 800 million won, up 16% and 46% respectively from the same period last year. The glass business division led the growth in the first quarter. The company was able to respond to market trends by proactively offering packaging materials in increasing demand within the healthcare industry. The continued expansion of the cosmetics and beauty market, as well as sustained demand for pre-filled syringes (PFS), also contributed to higher sales.

Chungmo Lee, CEO of HuM&C, said, "Our improved performance is the result of successfully establishing the Vietnam plant and continuously expanding our business portfolio," adding, "We will continue to anticipate market trends and respond swiftly to further strengthen our global competitiveness."

This content was produced with the assistance of AI translation services.